870
Views
20
CrossRef citations to date
0
Altmetric
Review Article

Quality of life and the role of menopausal hormone therapy

, &
Pages 213-216 | Received 06 Dec 2011, Accepted 23 Dec 2011, Published online: 22 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

C. Weber, F. Thönen, M. Zangger & P. Stute. (2022) Limitations in functioning in climacteric syndrome: a systematic literature review using the ICF. Climacteric 25:2, pages 155-162.
Read now
Kepa Balparda, Tatiana Herrera-Chalarca, Laura Andrea Silva-Quintero, Sneider Alexander Torres-Soto & Claudia Marcela Vanegas-Ramírez. (2020) Development and Validation of the “Keratoconus End-Points Assessment Questionnaire” (KEPAQ), a Disease-Specific Instrument for Evaluating Subjective Emotional Distress and Visual Function Through Rasch Analysis. Clinical Ophthalmology 14, pages 1287-1296.
Read now
R. J. Baber, N. Panay & A. Fenton$suffix/text()$suffix/text(). (2016) 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 19:2, pages 109-150.
Read now
Stephanie S Faubion, Ekta Kapoor, Carol L Kuhle, Richa Sood, Jacqueline M Thielen & Virginia M Miller. (2015) Recommendations for hormone therapy in hysterectomized women: importance of new data in clinical management. Expert Review of Endocrinology & Metabolism 10:1, pages 55-63.
Read now
Amos Pines. (2013) Climacteric Commentaries. Climacteric 16:4, pages 499-506.
Read now
T. J. de Villiers, A. Pines, N. Panay, M. Gambacciani, D. F. Archer, R. J. Baber, S. R. Davis, A. A. Gompel, V. W. Henderson, R. Langer, R. A. Lobo, G. Plu-Bureau & D. W. Sturdee. (2013) Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 16:3, pages 316-337.
Read now
Amos Pines. (2012) Climacteric commentaries. Climacteric 15:6, pages 632-636.
Read now
R. D. Langer, J. E. Manson & M. A. Allison. (2012) Have we come full circle – or moved forward? The Women's Health Initiative 10 years on. Climacteric 15:3, pages 206-212.
Read now

Articles from other publishers (11)

Tobias De Villiers. (2022) The management of vasomotor symptoms of menopause (VMS) with menopausal hormone therapy (MHT). Current Opinion in Endocrine and Metabolic Research 27, pages 100420.
Crossref
Nese Yuksel, Debra Evaniuk, Lina Huang, Unjali Malhotra, Jennifer Blake, Wendy Wolfman & Michel Fortier. (2021) Directive clinique no 422a : Ménopause : symptômes vasomoteurs, agents thérapeutiques d'ordonnance, médecines douces et complémentaires, nutrition et mode de vie. Journal of Obstetrics and Gynaecology Canada 43:10, pages 1205-1223.e1.
Crossref
Nese Yuksel, Debra Evaniuk, Lina Huang, Unjali Malhotra, Jennifer Blake, Wendy Wolfman & Michel Fortier. (2021) Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle. Journal of Obstetrics and Gynaecology Canada 43:10, pages 1188-1204.e1.
Crossref
Sa Ra LeeMoon Kyoung ChoYeon Jean ChoSungwook ChunSeung-Hwa HongKyu Ri HwangGyun-Ho JeonJong Kil JooSeul Ki KimDong Ock LeeDong-Yun LeeEun Sil LeeJae Yen SongKyong Wook YiBo Hyon YunJung-Ho ShinHee Dong Chae & Tak Kim. (2020) The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine 26:2, pages 69.
Crossref
Timothy McPherson, Patrick Fontane & Rhonda Bilger. (2019) Patient experiences with compounded medications. Journal of the American Pharmacists Association 59:5, pages 670-677.e2.
Crossref
No Author. (2019) Chapitre 4 : Symptômes vasomoteurs. Journal of Obstetrics and Gynaecology Canada 41, pages S68-S72.
Crossref
Quentin R. Regestein. (2017) The time has come for a safe, effective way to relieve menopausal symptoms. Menopause 24:10, pages 1113-1115.
Crossref
Guja Bernacchi, Stefania Spina, Elena Cecchi, Andrea R. Genazzani & Tommaso Simoncini. 2015. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology 167 175 .
. (2014) RETIRED: Managing Menopause Chapter 4 Vasomotor Symptoms. Journal of Obstetrics and Gynaecology Canada 36:9, pages S31-S34.
Crossref
Roger A. Lobo. (2013) Where Are We 10 Years After the Women's Health Initiative?. The Journal of Clinical Endocrinology & Metabolism 98:5, pages 1771-1780.
Crossref
Irwin Goldstein. (2012) The Effects of the Women's Health Initiative on Its 10th Year Anniversary. The Journal of Sexual Medicine 9:10, pages 2479-2482.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.